Advertisement
U.S. Markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
78.31+0.46 (+0.59%)
At close: 04:00PM EDT
78.39 +0.08 (+0.10%)
After hours: 07:25PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
49,133,000
45,811,000
44,351,000
37,417,000
26,617,000
-
Cost of Revenue
8,804,000
8,268,000
12,391,000
12,437,000
5,299,000
-
Gross Profit
40,329,000
37,543,000
31,960,000
24,980,000
21,318,000
-
Operating Expense
30,751,000
28,821,000
27,448,000
25,119,000
17,402,000
-
Operating Income
9,578,000
8,722,000
4,512,000
-139,000
3,916,000
-
Net Non Operating Interest Income Expense
-1,279,000
-1,288,000
-1,249,000
-1,233,000
-1,189,000
-
Pretax Income
7,746,000
6,899,000
2,501,000
-265,000
3,916,000
-
Tax Provision
1,301,000
938,000
-792,000
-380,000
772,000
-
Net Income Common Stockholders
6,440,000
5,955,000
3,288,000
112,000
3,196,000
-
Diluted NI Available to Com Stockholders
6,440,000
5,955,000
3,288,000
112,000
3,196,000
-
Basic EPS
1.90
1.92
1.06
0.04
1.22
-
Diluted EPS
1.89
1.91
1.05
0.04
1.22
-
Basic Average Shares
3,097,500
3,098,000
3,096,000
2,836,000
2,624,000
-
Diluted Average Shares
3,120,000
3,124,000
3,120,000
2,854,000
2,626,000
-
Total Operating Income as Reported
9,049,000
8,193,000
3,757,000
1,056,000
5,162,000
-
Rent Expense Supplemental
-
301,000
268,000
262,000
228,000
-
Total Expenses
39,555,000
37,089,000
39,839,000
37,556,000
22,701,000
-
Net Income from Continuing & Discontinued Operation
6,440,000
5,955,000
3,288,000
112,000
3,196,000
-
Normalized Income
6,846,869
6,375,540
3,888,210
-852,710
2,192,425
-
Interest Income
371,000
301,000
81,000
43,000
83,000
-
Interest Expense
1,650,000
1,589,000
1,330,000
1,276,000
1,272,000
-
Net Interest Income
-1,279,000
-1,288,000
-1,249,000
-1,233,000
-1,189,000
-
EBIT
9,396,000
8,488,000
3,831,000
1,011,000
5,188,000
-
EBITDA
14,086,000
13,422,000
9,085,000
5,113,000
8,084,000
-
Reconciled Cost of Revenue
8,804,000
8,268,000
12,391,000
12,437,000
5,299,000
-
Reconciled Depreciation
4,690,000
4,934,000
5,254,000
4,102,000
2,896,000
-
Net Income from Continuing Operation Net Minority Interest
6,440,000
5,955,000
3,288,000
112,000
3,196,000
-
Total Unusual Items Excluding Goodwill
-489,000
-489,000
-741,000
1,191,000
1,250,000
-
Total Unusual Items
-489,000
-489,000
-741,000
1,191,000
1,250,000
-
Normalized EBITDA
14,575,000
13,911,000
9,826,000
3,922,000
6,834,000
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-82,131
-68,460
-140,790
226,290
246,425
-